Skip to content

Lifevantage Corporation LFVN Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

NuSkin Enterprises logo
NuSkin EnterprisesNUS
NAG
Niagen Bioscience, Inc. Common StockNAGE
Celsius Holdings, Inc. logo
Celsius Holdings, Inc.CELH

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.4%
Enterprise value$76.45M-50.2%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio+0.3×

Where this comes from

Reported directly by Lifevantage Corporation in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifevantage Corporation's remainder of fiscal year 2024?
Lifevantage Corporation (LFVN) reported remainder of fiscal year 2024 of $548K in Q1 2026.
How has Lifevantage Corporation's remainder of fiscal year 2024 changed year-over-year?
Lifevantage Corporation's remainder of fiscal year 2024 decreased by 4.9% year-over-year, from $576K to $548K.